Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Todd M. Brown"'
Autor:
Vera Bittner, Adam P. Bress, Bharat Poudel, Katherine E Mues, Ying Wen, Calvin L. Colvin, Robert S. Rosenson, Ligong Chen, Lisandro D. Colantonio, Catherine G. Derington, Keri L. Monda, Paul Muntner, Jordan B. King, Elizabeth A. Jackson, Todd M. Brown
Publikováno v:
Journal of Clinical Lipidology. 15:665-673
Background Adults with atherosclerotic cardiovascular disease (ASCVD) at very high-risk for recurrent events who have low-density lipoprotein cholesterol ≥ 70 mg/dL despite maximally-tolerated statin therapy are recommended to initiate ezetimibe or
Autor:
Todd M. Brown, Melissa K Van Dyke, Meredith L. Kilgore, Matthew Shane Loop, Ligong Chen, Raegan W. Durant, Emily B. Levitan, Monika M. Safford
Publikováno v:
Journal of Cardiac Failure. 25:343-351
Background The evidence-based beta-blockers carvedilol, bisoprolol, and metoprolol succinate reduce mortality and hospitalizations among patients with heart failure with reduced ejection fraction (HFrEF). Use of these medications is not well describe
Autor:
Robert S. Rosenson, Lisandro D. Colantonio, Keri L. Monda, Michael E. Farkouh, Yuling Dai, Mark Woodward, Todd M. Brown, Demetria Hubbard, Lei Huang, Katherine E Mues, Elizabeth A. Jackson, Paul Muntner
Publikováno v:
Journal of the American College of Cardiology. 76(3)
Background Peripheral artery disease (PAD) is associated with increased risk for atherosclerotic cardiovascular disease (ASCVD) events. Objectives The goal of this study was to compare the risk for ASCVD events and the use of statins among patients w
Autor:
April P. Carson, Keri L. Monda, Todd M. Brown, Yuling Dai, Lisandro D. Colantonio, Gennaro Giustino, Paul Muntner, Michael E. Farkouh, Robert S. Rosenson
Publikováno v:
Cardiovascular Drugs and Therapy. 32:453-461
Patients with diabetes mellitus (DM) have a high risk for cardiovascular disease (CVD) events after an acute myocardial infarction (AMI). High-intensity statins reduce CVD risk following AMI among patients with and without DM. We determined the propo
Autor:
Melissa K Van Dyke, Todd M. Brown, Karen C. Albright, Justin Blackburn, J. David Rhodes, Ligong Chen, Meredith L. Kilgore, Monika M. Safford, Olusola Olubowale, Emily B. Levitan, Oluwole Adegbala, Raegan W. Durant
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Less intensive treatment for heart failure with reduced ejection fraction (HFrEF) may be appropriate for patients in long-term care settings because of limited life expectancy, frailty, comorbidities, and emphasis on quality of life. Metho
Autor:
Hong Zhao, Paul Muntner, Keri L. Monda, Ben Taylor, Yuling Dai, Matthew T. Mefford, Vera Bittner, Todd M. Brown, Michael E. Farkouh, Robert S. Rosenson
Publikováno v:
Journal of the American College of Cardiology. 69:2696-2706
Background Data prior to 2011 suggest that a low percentage of patients hospitalized for acute coronary syndromes filled high-intensity statin prescriptions upon discharge. Black-box warnings, generic availability of atorvastatin, and updated guideli
Autor:
Todd M. Brown, Maria-Corina Serban, Lisandro D. Colantonio, Mark Woodward, Vera Bittner, Robert S. Rosenson, Ransi Somaratne, Hong Zhao, Michael E. Farkouh, Nita A. Limdi, Paul Muntner, Keri L. Monda, Luqin Deng
Publikováno v:
Journal of clinical lipidology. 14(2)
Background High-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and antiplatelet agents (ie, intensive medical management) reduce coronary heart disease (CHD) risk after myocardial infarction
Autor:
Todd M. Brown, Monika M. Safford, Parag Goyal, Raegan W. Durant, Matthew Shane Loop, Emily B. Levitan, Ligong Chen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background It is unknown whether causes and temporal patterns of 30‐day readmission vary between heart failure (HF) with preserved ejection fraction ( HF p EF ) and HF with reduced ejection fraction ( HF r EF ). We sought to address this question b
Autor:
Monika M. Safford, Lisandro D. Colantonio, Robert Rosenson, Todd M. Brown, Ligong Chen, Emily B. Levitan, Paul Muntner, Keri Monda, John N. Booth, Meredith L. Kilgore, Ricardo Dent, Benjamin B. Taylor
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 10
Background— Although the benefits of statins accrue over time, treatment discontinuation is common. Examining the patterns of statin discontinuation, reinitiation, and persistence after reinitiation among Medicare beneficiaries after hospital disch
Autor:
Michael E. Farkouh, Monika M. Safford, Robert S. Rosenson, Todd M. Brown, Vera Bittner, Emily B. Levitan, Shia T. Kent, Pankaj Sharma, Meredith L. Kilgore, Huifeng Yun, Paul Muntner
Publikováno v:
Journal of the American College of Cardiology. 65(3):270-277
Background National guidelines recommend use of high-intensity statins after hospitalization for coronary heart disease (CHD) events. Objectives This study sought to estimate the proportion of Medicare beneficiaries filling prescriptions for high-int